The global glycomics market size was valued at USD 7.16 billion in 2024 and is expected to reach USD 20.79 billion by 2032, at a CAGR of 14.25% during the forecast period
The market growth is largely fueled by the increasing recognition of glycans' roles in various biological processes and disease mechanisms, particularly in areas such as cancer and autoimmune disorders. This understanding is leading to significant investments in glycomic research and advancements in analytical technologies
Furthermore, rising consumer demand for personalized medicine and novel drug development is establishing glycomics as a crucial tool in identifying biomarkers and developing targeted therapies. These converging factors are accelerating the uptake of glycomics solutions, thereby significantly boosting the industry's growth
